Pulmonary Infection After Ischemic Stroke (PICAS)
June 20, 2023 updated by: Ji Xunming,MD,PhD, Capital Medical University
Pulmonary Infection and Clinical Pneumonia After Ischemic Stroke
To assess the frequency of signs of pulmonary infection on a chest CT and development of clinical diagnose of poststroke pneumonia，and its effect on functional outcome in patients with acute ischemic stroke.
Study Overview
Status
Recruiting
Study Type
Observational
Enrollment (Estimated)
500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Xunming Ji, MD
- Phone Number: 010-83199439
- Email: jixm@ccmu.edu.cn
Study Contact Backup
- Name: Nan Yang, MM
- Email: 384487208@qq.com
Study Locations
-
-
-
Beijing, China, 100053
- Recruiting
- Xuanwu Hospital, Capital Medical University
-
Contact:
- Nan Yang, MM
- Email: 384487208@qq.com
-
-
An Hui
-
Suzhou, An Hui, China
- Recruiting
- Suzhou Municipal Hospital
-
Contact:
- Zhengfei Ma, MD
-
-
Hebei
-
Baoding, Hebei, China
- Recruiting
- People Hospital of Rongcheng
-
Contact:
- Mengge Zhang, MM
-
Shijiazhuang, Hebei, China
- Recruiting
- The Second Hospital of Hebei Medical University
-
Contact:
- Fang Xue, MD
-
Xingtai, Hebei, China
- Recruiting
- People Hospital of Ningjin
-
Contact:
- Fei Gu, MD
-
-
Xinjiang
-
Shihezi, Xinjiang, China
- Recruiting
- Shihezi Municipal Hospital
-
Contact:
- Naren Ya
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
had a computed tomography scan of the chest within 24 hours after stroke onset
Description
Inclusion Criteria:
Have a computed tomography scan of the chest within 24 hours after stroke onset
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
had a computed tomography scan of the chest within 24 hours after stroke onset
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
With radiological signs of pulmonary infection
Time Frame: 24 hours
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
development of clinical poststroke pneumonia
Time Frame: 2 weeks or at discharge
|
2 weeks or at discharge
|
|
modified Rankin Scale
Time Frame: 90 days
|
90 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2022
Primary Completion (Actual)
January 20, 2023
Study Completion (Estimated)
July 20, 2023
Study Registration Dates
First Submitted
June 20, 2023
First Submitted That Met QC Criteria
June 20, 2023
First Posted (Actual)
June 28, 2023
Study Record Updates
Last Update Posted (Actual)
June 28, 2023
Last Update Submitted That Met QC Criteria
June 20, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PICAS
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.